EUVIMEDEUVIMED entdecken
ÜbersichtsarbeitOpen Access · CC BY 4.0

Metabolomic Profiling of Tyrosine Kinase Inhibitor-Induced Endothelial Dysfunction and Cardiovascular Toxicity

Gurkaranvir Singh, Inderjeet Bharaj iD, Joey Bettencourt, Amarjit Kaur Sekhon, Gurparvesh Singh, Aaron Sidhu, Emanuel Zayas Diaz, Sulaiman Paika, Ariel De Leon, Ajit Brar iD, Gursimran Brar, Inderbir Padda und 1 weitere

Metabolites · 17.03.2026 · 16 (3) · 200

DOI: 10.3390/metabo16030200 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift Metabolites, online erschienen am 17.03.2026. Verfasst von Gurkaranvir Singh und 12 weiteren Autor:innen. Beteiligte Einrichtung: Department of Medicine, School of Medicine, Creighton University, Phoenix, AZ 85012, USA. Die Arbeit nennt 100 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

Tyrosine kinase inhibitors (TKIs) have transformed cancer therapy; however, they are associated with cardiovascular toxicity. Metabolomics provides a comprehensive framework for identifying early biochemical disruptions that precede clinical manifestations and for formulating mechanism-based intervention strategies.

Methods

We conducted a narrative synthesis of published preclinical and translational studies on TKI cardiotoxicity, focusing on untargeted and targeted metabolomic findings and complementary proteomic and transcriptomic data. Functional validation was performed using rodent and cellular models. Mechanistic themes were identified, and implications for biomarker panels, multi-omic integration, and metabolomics-guided interventions were proposed.

Conclusions

Metabolomic analyses of various TKIs identified convergent signatures along three interconnected axes: (1) mitochondrial bioenergetic dysfunction characterized by impaired long-chain fatty acid oxidation and adenylate depletion; (2) disruption of endothelial nitric oxide signaling with redox imbalance, including increased nitrotyrosine, Nox activation, and eNOS uncoupling; and (3) an inflammatory metabolic profile marked by elevated branched-chain and aromatic amino acids, creatine, and osmolytes. Rodent models of sunitinib and sorafenib replicate these signatures and demonstrate histological injury, contractile dysfunction, and fibrosis. Preclinical intervention data, particularly restoration of myocardial carnitine, AMPK signaling, and fatty acid oxidation by L-carnitine, provide proof of concept for metabolomics-guided cardioprotection. Metabolomics can identify mechanistic biomarkers that facilitate the early detection, risk stratification, and targeted prevention of TKI-induced cardiovascular injury. Translation into precision cardio-oncology requires prospective validation, standardized assays, and biomarker-driven interventional trials.

Schlagwörter

Stichwörter der Autor:innen

L-carnitinecardiotoxicityendothelial dysfunctionmetabolomicstyrosine kinase inhibitors

Autor:innen und Institutionen

  • Department of Medicine, School of Medicine, Creighton University, Phoenix, AZ 85012, USA.
  • Department of Medicine, Abrazo Health Network, Glendale, AZ 85308, USA.
  • Department of Hematology and Oncology, Cleveland Clinic Weston Hospital, Weston, FL 33331, USA.
  • Department of Medicine, Hurley Medical Center, Michigan State University, Flint, MI 48503, USA.
  • Department of Medicine, Punjab Institute of Medical Sciences and Research, Jalandhar 144001, Punjab, India.
  • Department of Internal Medicine, Richmond University Medical Center/Mount Sinai, Staten Island, NY 10310, USA.

ORCID-Profile: Inderjeet Bharaj, Ajit Brar

Zitieren

APA

Singh, G., Bharaj, I., Bettencourt, J., Sekhon, A. K., Singh, G., Sidhu, A., Diaz, E. Z., Paika, S., Leon, A., Brar, A., Brar, G., Padda, I., & Andrade, A. (2026). Metabolomic Profiling of Tyrosine Kinase Inhibitor-Induced Endothelial Dysfunction and Cardiovascular Toxicity. Metabolites, 16(3), 200. https://doi.org/10.3390/metabo16030200

Vancouver

Singh G, Bharaj I, Bettencourt J, Sekhon AK, Singh G, Sidhu A, et al. Metabolomic Profiling of Tyrosine Kinase Inhibitor-Induced Endothelial Dysfunction and Cardiovascular Toxicity. Metabolites. 2026;16(3):200. doi:10.3390/metabo16030200

BibTeX
@article{Singh2026,
  author = {Singh, Gurkaranvir and Bharaj, Inderjeet and Bettencourt, Joey and Sekhon, Amarjit Kaur and Singh, Gurparvesh and Sidhu, Aaron and Diaz, Emanuel Zayas and Paika, Sulaiman and Leon, Ariel De and Brar, Ajit and Brar, Gursimran and Padda, Inderbir and Andrade, Ambar},
  title = {Metabolomic Profiling of Tyrosine Kinase Inhibitor-Induced Endothelial Dysfunction and Cardiovascular Toxicity},
  journal = {Metabolites},
  year = {2026},
  volume = {16},
  number = {3},
  pages = {200},
  doi = {10.3390/metabo16030200}
}
Kostenlos starten →